Boulder-based OPX Biotechnologies Inc. recently raised $36.5 million, funds that officials say will be crucial toward the demonstration and eventual commercialization of bioacrylic products, the Daily Camera reported Wednesday.
The Denver Post, Denver Post: Business
Wed, 07/06/2011 - 8:20pm
Boulder-based OPX Biotechnologies Inc. recently raised $36.5 million, funds that officials say will be crucial toward the demonstration and eventual commercialization of bioacrylic products, the Daily Camera reported Wednesday.